Hide table of contents

I'm referring to general traumatic experiences – both the ones that might more typically come to mind like witnessing a violent event and things like this, but also more "microtraumas" like getting bullied at school.

My hypothesis might be that reducing trauma could improve human co-operation and coordination. The logic might be that trauma means that when people communicate they accidentally "trigger" something below the surface in the other person, and so then the conversation becomes about something that it's not ostensibly about, and cooperation becomes harder.

You could imagine an experiment where there are X "trauma-free" people and a varying number of people with some level of trauma doing a task that requires cooperation and coordination of all participants to solve, and then comparing the "time-to-solve" and success rates, to see how much coordination and cooperation might be improved by solving trauma.

New Answer
New Comment


4 Answers sorted by

To put a brighter spin on what other people have said about tractability, many EA-backed cause areas reduce trauma already, too. If a child doesn't die of malaria, their siblings and parents are also spared the huge trauma of experiencing the death of a family member.

MDMA therapy is showing a lot of promise as a treatment for post-traumatic stress disorder.

Here's an excerpt from my recent "prizes for arguments against psychedelics being an EA cause area" post:

---

3(d). Trauma alleviation

Childhood trauma is plausibly upstream of several burdensome problems. See this excerpt from The Body Keeps Score, a pop-sci review of academic trauma research (on p. 150):


The first time I heard Robert Anda present the results of the ACE study, he could not hold back his tears. In his career at the CDC he had previously worked in several major risk areas, including tobacco research and cardiovascular health.
But when the ACE study data started to appear on his computer screen, he realized that they had stumbled upon the gravest and most costly public health issue in the United States: child abuse.
[Anda] had calculated that its overall costs exceeded those of cancer or heart disease and that eradicating child abuse in America would reduce the overall rate of depression by more than half, alcoholism by two-thirds, and suicide, IV drug use, and domestic violence by three-quarters. It would also have a dramatic effect on workplace performance and vastly decrease the need for incarceration.

Psychedelic therapy seems very promising for resolving PTSD, which could plausibly break the cycle of abuse that creates new traumatic experiences. (Trauma appears to transfer from generation to generation via multiple pathways.)

In particular, MDMA-assisted psychotherapy for PTSD is yielding extremely promising results in recent randomized controlled trials (see Mithoefer et al. 2012, Mithoefer et al. 2018, Ot’alora et al. 2018). From the abstract of Mithoefer et al. 2018:


At the primary endpoint, the 75 mg and 125 mg groups had significantly greater decreases in PTSD symptom severity (mean change CAPS-IV total scores of −58·3 [SD 9·8] and −44·3 [28·7]; p=0·001) than the 30 mg group (−11·4 [12·7]). Compared with the 30 mg group, Cohen's d effect sizes were large: 2·8 (95% CI 1·19–4·39) for the 75 mg group and 1·1 (0·04–2·08) for the 125 mg group.
PTSD symptoms were significantly reduced at the 12-month follow-up compared with baseline after all groups had full-dose MDMA (mean CAPS-IV total score of 38·8 [SD 28·1] vs 87·1 [16·1]; p<0·0001).

A Cohen’s d of 2.8 is extremely large (“Cohen suggested that d = 0.2 be considered a 'small' effect size, 0.5 represents a 'medium' effect size and 0.8 a 'large' effect size” source). Here’s a good resource for interpreting Cohen’s d.

In this study, 30 mg of MDMA was used as an active placebo, and the intervention groups were given 75 mg or 125 mg of MDMA.

From Mithoefer et al. 2012, a long-term follow-up of the first MDMA RCT:


We found the majority of these subjects with previously severe PTSD who were unresponsive to existing treatments had symptomatic relief provided by MDMA-assisted psychotherapy that persisted over time...

MDMA helped resolve severe PTSD symptoms in patients who had not responded to other treatment regimens. For 86% of patients, this benefit persisted 17+ months after the MDMA session.

Yes, agreed. In particular though I'm wondering about the "impact" piece and separate of possible interventions/tractability, how trauma might rate on the "impact" and "neglectedness" pieces.

2
Milan Griffes
Don't the studies I point to suggest a large impact? From my answer:
1
nonzerosum
I mean EA impact of reducing trauma, not impact of MDMA therapy on trauma (which I agree seems large). Similar to how 80000hours gives a ranking of the 'impact' of different causes, I wonder how "reducing trauma" would compare on their impact assessment.

Reducing trauma seems good as something that improves human flourishing
// reduces suffering, more than as something which "improves coordination". But it doesn't stand out to me as something that seems better than any of the major established cause areas.

EA cause areas aren't just about the scale of an issue -- to be plausible candidates, they require methods to address the issue that are proven or at least promising. Are you aware of any extremely efficient ways to reduce trauma? Is trauma something that can easily be measured (maybe secondarily through stress hormones)?

People interested in this topic may find value in Michael Plant's look at mental illness, an area where we have some evidence for the existence of a reasonably cheap and effective treatment.

Are you aware of any extremely efficient ways to reduce trauma ?

There are several promising canidates that show high enough efficacy to do more research. Drugs therapies such as MDMA show promise, as do therepeutic techniques like RTM. (RTM is particularly promising because it appears to be quick, cheap, and highly effective).


Is trauma something that can easily be measured.

Of course. Like most established constructs in psychology, there are both diagnostic criteria for assesment by trained professionals and self-report indexes. Most of these tend to be ... (read more)

Are you aware of any extremely efficient ways to reduce trauma? Is trauma something that can easily be measured (maybe secondarily through stress hormones)?

There are well-validated instruments for measuring post-traumatic stress disorder. MDMA therapy is proving highly effective at treating PTSD (see my answer for evidential support).

more than as something which "improves coordination"

What makes you say that? I have the sense that the less trauma people have, the easier they'll find it, and the more desire they'll have, to co-operate and coordinate.

2
Aaron Gertler 🔸
What makes you think that this secondary effect, which requires trauma reduction in an enormous number of people (to generate network effects) or a tightly-knit group of people, would have a greater impact than the primary effect of "people have less trauma and feel better"?
1
nonzerosum
Thanks for that question! Weakly held. Some sense that we're under-invested in "improving coordination" (see: http://www.existential-risk.org/concept.pdf). But it's a good point that it would be hard! And I agree that tightly knit groups may be a better approach for this. e.g. trauma reduction for a group of AI safety researchers to help them better coordinate, or something like that.
1
nonzerosum
And I'm also very interested in the direct impact, too.

"You could imagine an experiment where there are X "trauma-free" people"

I cannot imagine that experiment. I've never met someone who hasn't experienced something at least mildly traumatic.

Curated and popular this week
 ·  · 32m read
 · 
Summary Immediate skin-to-skin contact (SSC) between mothers and newborns and early initiation of breastfeeding (EIBF) may play a significant and underappreciated role in reducing neonatal mortality. These practices are distinct in important ways from more broadly recognized (and clearly impactful) interventions like kangaroo care and exclusive breastfeeding, and they are recommended for both preterm and full-term infants. A large evidence base indicates that immediate SSC and EIBF substantially reduce neonatal mortality. Many randomized trials show that immediate SSC promotes EIBF, reduces episodes of low blood sugar, improves temperature regulation, and promotes cardiac and respiratory stability. All of these effects are linked to lower mortality, and the biological pathways between immediate SSC, EIBF, and reduced mortality are compelling. A meta-analysis of large observational studies found a 25% lower risk of mortality in infants who began breastfeeding within one hour of birth compared to initiation after one hour. These practices are attractive targets for intervention, and promoting them is effective. Immediate SSC and EIBF require no commodities, are under the direct influence of birth attendants, are time-bound to the first hour after birth, are consistent with international guidelines, and are appropriate for universal promotion. Their adoption is often low, but ceilings are demonstrably high: many low-and middle-income countries (LMICs) have rates of EIBF less than 30%, yet several have rates over 70%. Multiple studies find that health worker training and quality improvement activities dramatically increase rates of immediate SSC and EIBF. There do not appear to be any major actors focused specifically on promotion of universal immediate SSC and EIBF. By contrast, general breastfeeding promotion and essential newborn care training programs are relatively common. More research on cost-effectiveness is needed, but it appears promising. Limited existing
 ·  · 11m read
 · 
Our Mission: To build a multidisciplinary field around using technology—especially AI—to improve the lives of nonhumans now and in the future.  Overview Background This hybrid conference had nearly 550 participants and took place March 1-2, 2025 at UC Berkeley. It was organized by AI for Animals for $74k by volunteer core organizers Constance Li, Sankalpa Ghose, and Santeri Tani.  This conference has evolved since 2023: * The 1st conference mainly consisted of philosophers and was a single track lecture/panel. * The 2nd conference put all lectures on one day and followed it with 2 days of interactive unconference sessions happening in parallel and a week of in-person co-working. * This 3rd conference had a week of related satellite events, free shared accommodations for 50+ attendees, 2 days of parallel lectures/panels/unconferences, 80 unique sessions, of which 32 are available on Youtube, Swapcard to enable 1:1 connections, and a Slack community to continue conversations year round. We have been quickly expanding this conference in order to prepare those that are working toward the reduction of nonhuman suffering to adapt to the drastic and rapid changes that AI will bring.  Luckily, it seems like it has been working!  This year, many animal advocacy organizations attended (mostly smaller and younger ones) as well as newly formed groups focused on digital minds and funders who spanned both of these spaces. We also had more diversity of speakers and attendees which included economists, AI researchers, investors, tech companies, journalists, animal welfare researchers, and more. This was done through strategic targeted outreach and a bigger team of volunteers.  Outcomes On our feedback survey, which had 85 total responses (mainly from in-person attendees), people reported an average of 7 new connections (defined as someone they would feel comfortable reaching out to for a favor like reviewing a blog post) and of those new connections, an average of 3
GiveWell
 ·  · 2m read
 · 
Recent cuts to US government foreign assistance have destabilized global health programs, impacting some of the most cost-effective interventions we’ve found for saving and improving lives, such as malaria nets, malaria chemoprevention, and community-based management of acute malnutrition. This situation is a major focus of our research team at the moment, and we’re working to balance a targeted, near-term response to urgent needs with a broad, long-term perspective of needs that may emerge. The US has historically provided roughly 20% to 25% ($12 billion to $15 billion) of the total global aid to support health programs, which combat malaria, tuberculosis, HIV, maternal and child health issues, and much more.[1] While the long-term effects remain uncertain and exact numbers remain difficult to ascertain, cuts of 35% to 90% of US foreign aid dollars are being publicly discussed by the administration.[2] We’ve created a webpage to provide an overview of how we’re responding, and we’ve started to record a series of conversations with our research team that shares timely snapshots of this rapidly evolving situation. Our first episode shared a broad overview of the impacts of US government aid cuts and GiveWell’s initial response. In our newly released second episode, GiveWell Program Officer Natalie Crispin joins CEO and co-founder Elie Hassenfeld to zoom in on a specific case, focusing on grants we’ve made to support urgent funding gaps for seasonal malaria chemoprevention (SMC). They discuss how SMC campaigns work, the impact of USAID funding pauses on SMC campaigns, and GiveWell’s response to keep SMC campaigns on track.   Listen to Episode 2: Addressing Urgent Needs in Seasonal Malaria Chemoprevention   This situation is changing daily, and we’re constantly learning more. You can listen or subscribe to our podcast for the latest updates and read a summary of key takeaways from each podcast conversation on our blog. GiveWell has so far directed approximately
Relevant opportunities